curasafehealthcare.com
  • Home
  • About
  • Services
  • Therapeutic Areas
  • Careers
  • Latest News
  • Contact Us
Select Page

Red Light Therapy: a Potential Strategy to Reduce Sports Injury Risk?

by palligoelme@gmail.com | Mar 19, 2026 | Clinical Trials

​ Conditions: Ankle Dorsiflexion Interventions: Device: Near-infrared photobiomodulation; Other: Cycling Warm-up Sponsors: Cláudio da Silva Ferreira Not yet recruiting Conditions: Ankle Dorsiflexion Interventions: Device: Near-infrared photobiomodulation; Other:...

Safety and Efficacy Evaluation of an Extensively Hydrolyzed Formula in Infants With Cow’s Milk Protein Allergy (CMPA)

by palligoelme@gmail.com | Mar 19, 2026 | Clinical Trials

​ Conditions: Cow’s Milk Protein Allergy (CMPA) Interventions: Other: Feihe Extensively Hydrolyzed Formula; Other: Nestlé Extensively Hydrolyzed Formula Sponsors: Heilongjiang Feihe Dairy Co. Ltd. Not yet recruiting Conditions: Cow’s Milk Protein Allergy...

Skin Adhesive Plus Intra-cuticular Suture Versus Suture Alone for Cesarean Skin Closure: Randomized Controlled Trial

by palligoelme@gmail.com | Mar 19, 2026 | Clinical Trials

​ Conditions: Surgical Site Infection (SSI) Interventions: Other: Dermabond Sponsors: Doron Kabiri Recruiting Conditions: Surgical Site Infection (SSI) Interventions: Other: Dermabond Sponsors: Doron Kabiri Recruiting 

Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis

by palligoelme@gmail.com | Mar 19, 2026 | Clinical Trials

​ Conditions: Primary Progressive Multiple Sclerosis; Secondary Progressive Multiple Sclerosis (SPMS); Multiple Sclerosis; Multiple Sclerosis (MS) Primary Progressive; Multiple Sclerosis (MS) Secondary Progressive Interventions: Biological: TRX319; Drug: Bendamustine...

Liquid Biopsy Monitoring Of EGFR T790M in Advanced Non-Small Cell Lung Cancer

by palligoelme@gmail.com | Mar 19, 2026 | Clinical Trials

​ Conditions: Non-Small Cell Lung Cancer Sponsors: Faculty of Medicine of Tunis; Hopital Charles Nicolle Completed Conditions: Non-Small Cell Lung Cancer Sponsors: Faculty of Medicine of Tunis; Hopital Charles Nicolle Completed 

Tumor Microenvironment Changes After Neoadjuvant Chemo-Immunotherapy in Esophageal Squamous Cell Carcinoma

by palligoelme@gmail.com | Mar 19, 2026 | Clinical Trials

​ Conditions: Esophageal Squamous Cell Carcinoma Interventions: Other: Biological: Tumor Tissue and Blood Sample Collection Sponsors: Nanjing Medical University Not yet recruiting Conditions: Esophageal Squamous Cell Carcinoma Interventions: Other: Biological: Tumor...
« Older Entries
Next Entries »

Recent Posts

  • [Trial of device that is not approved or cleared by the U.S. FDA]
  • Predictive Role of Photon Counting Computed Tomography in Acute Coronary Syndrom Patients
  • Effects of Concurrent Aerobic and Resistance Training After Bariatric Surgery in Women: RCT
  • Effect of Adding PNF to IMT on Weaning Off MV
  • The Effect of Myopia-Control Contact Lenses in New Zealand Chinese Children

Recent Comments

No comments to show.

Curasafe healthcare solutions Pvt. Ltd. provides comprehensive services including safety program oversight, risk management, and regulatory compliance.

Important Links

  • Home
  • Contact Us
Connect With Us

Contact


711, Shivalik Satyamev, Bopal Ambli Junction, Bopal, Ahmedabad, Daskroi, Gujarat, India, 380058.


info@curasafehealthcare.com



(+91) 97803 81065

Copyright © 2025 Curasafehealthcare ®